Drug Safety

, Volume 14, Issue 6, pp 406–423 | Cite as

Drug-Induced Pancreatitis

  • Teun Wilmink
  • Thomas W. Frick
Review Article Pharmacoepidemiology

Summary

Few data exist about the incidence of drug-induced pancreatitis in the general population. 20 cases of drug-related pancreatitis were reported in Switzerland over a period of 12 years. The proportion of cases of pancreatitis caused by drugs is estimated to be around 2% in the general population, with much higher proportions in specific subpopulations, such as children and patients who are HIV positive. The literature about drug-induced pancreatitis consists mainly of anecdotal case reports. Clear evidence of a definite association with pancreatitis, by means of rechallenge tests, or consistent case reports, supported by animal experiments or data on the incidence of acute pancreatitis in drug trials exists for didanosine, valproic acid (sodium valproate), aminosalicylates, estrogen, calcium, anticholinesterases and sodium stibogluconate. An association with drug-induced pancreatitis is likely but not definitely proven for thiazide diuretics, pentamidine, ACE inhibitors, asparaginase, vinca alkaloids, some nonsteroidal anti-inflammatory drugs and clozapine. Pancreatitis is possibly caused by azathioprine, furosemide (frusemide), tetracycline, metronidazole, isoniazid, rifampicin (rifampin), sulphonamides, cyclosporin and some antineoplastic drugs. Many drugs have been reported to be associated with acute pancreatitis. However, lack of rechallenge evidence, consistent statistical data, or evidence from experimental studies on a possible mechanism prohibit definitive conclusions about most of them. The high incidence of concurrent illnesses known to induce acute pancreatitis, makes a trigger role or co-factor role for the drug seem most likely.

Keywords

Pancreatitis Adis International Limited Acute Pancreatitis Valproic Acid Visceral Leishmaniasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Werth B, Kuhn MK H, Reinhart WH. Medikamentös induzierte Pankreatiden: Erfahrungen der Schweizerischen Arzneimittel-Nebenwirkungenszentrale (SANZ) 1981–1993. Schweiz Med Wochenschr 1995; 125: 731–4PubMedGoogle Scholar
  2. 2.
    Steinberg W. Acute pancreatitis. N Engl J Med 1994; 330(17): 1198–210PubMedCrossRefGoogle Scholar
  3. 3.
    Corfield AP, Cooper MJ, Williamson RCN. Acute pancreatitis: a lethal disease of increasing incidence. Gut 1985; 26: 724–9PubMedCrossRefGoogle Scholar
  4. 4.
    Thomson S, Hendry W, McFarlane G, et al. Epidemiology and outcome of acute pancreatitis. Br J Surg 1987; 74: 398–401PubMedCrossRefGoogle Scholar
  5. 5.
    Lankisch PG, Dräge M, Gottesleben F. Drug induced pancreatitis: incidence and severity. Gut 1995; 37: 565–7PubMedCrossRefGoogle Scholar
  6. 6.
    Cappell MS, Marks M. Acute pancreatitis in HIV-seropositive patients: a case control study in 44 patients. Am J Med 1995; 98: 243–8PubMedCrossRefGoogle Scholar
  7. 7.
    Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA 1975; 234(12): 1236–41PubMedCrossRefGoogle Scholar
  8. 8.
    Bireher J. Criteria for the diagnosis of adverse drug reactions. Baillieres Clin Gastroenterol 1988; 2: 259–61CrossRefGoogle Scholar
  9. 9.
    Bouvert E, Casalino E, Prevost M, et al. Fatal case of 2′,3′-dideoxyinosine-associated pancreatitis. Lancet 1990; 336: 1515CrossRefGoogle Scholar
  10. 10.
    Schindzielorz A, Pike I, Daniels M, et al. Rates and risk factors for adverse events associated with didanosine in the expanded access program. Clin Infect Dis 1994; 19(6): 1076–83PubMedCrossRefGoogle Scholar
  11. 11.
    Maxson C, Greenfield S, Turner J. Acute pancreatitis as a common complication of 2′3′-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992; 87(6): 708–13PubMedGoogle Scholar
  12. 12.
    Yarchoan R, Mitsuya H, Pluda J, et al. The national cancer institute phase I study of 2′,3′-dideoxyinosine administration in adults with AIDS-related complex: analysis of activity and toxicity profiles. Rev Infect Dis 1990; 12: S522–S233PubMedCrossRefGoogle Scholar
  13. 13.
    Valentine F, Seidlin M, Hockster H, et al. Phase I study of 2′,3′-dideoxyinosine: experience with 19 patients at New York University Medical Center. Rev Infect Dis 1990; 12: S534–S539PubMedCrossRefGoogle Scholar
  14. 14.
    Rozencweig M, McLaren C, Beltangady M, et al. Overview of Phase I trials of 2′,3′-dideoxyinosine (ddl) conducted on adult patients. Rev Infect Dis 1990; 12: S570–S575PubMedCrossRefGoogle Scholar
  15. 15.
    Dolin R, Lambert J, Morse G, et al. 2′3′-Dideoxyinosine in patients with AIDS or AIDS-related complex. Rev Infect Dis 1990; 12: S540–S551PubMedCrossRefGoogle Scholar
  16. 16.
    Butler K, Husson R, Balis F, et al. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991; 324: 137–144PubMedCrossRefGoogle Scholar
  17. 17.
    Cooley T, Knuches L, Saunders C, et al. Treatment of AIDS and AIDS-related complex with 2′,3′-dideoxyinosine given once daily. Rev Infect Dis 1990; 12: S552–S560PubMedCrossRefGoogle Scholar
  18. 18.
    Seidlin M, Lambert JS, Dolin R, et al. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS 1992; 6: 831–5PubMedCrossRefGoogle Scholar
  19. 19.
    Grasela T, Walawander C, Beltangady M, et al. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis 1994; 169: 1250–5PubMedCrossRefGoogle Scholar
  20. 20.
    Butler K, Venzon D, Henry N, et al. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics 1993; 91: 747–51PubMedGoogle Scholar
  21. 21.
    Lambert J, Seidlin M, Valentine F, et al. Didanosine: long term follow up of patients in a phase I study CID 1993; 16(Suppl. 1): S40–S45CrossRefGoogle Scholar
  22. 22.
    Moyle G, Nelson M, Hawkins D, et al. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT). Q J Med 1993; 86: 155–63PubMedGoogle Scholar
  23. 23.
    Brivet F, Coffin B, Bedossa P, et al. Pancreatic lesions in AIDS. Lancet 1987; II: 570–1CrossRefGoogle Scholar
  24. 24.
    Clas D, Falutz J, Rosenberg L. Acute pancreatitis associated with HIV infection. Can Med Assoc J 1989; 140: 823Google Scholar
  25. 25.
    Schwartz M, Brandt L. The spectrum of pancreatic disorders in patients with the Acquired Immune Deficiency Syndrome. Am J Gastroenterol 1989; 84(5): 459–62PubMedGoogle Scholar
  26. 26.
    Asconape J, Penry J, Dreifuss F, et al. Valproate-associated pancreatitis. Epilepsia 1993; 34: 177–83PubMedCrossRefGoogle Scholar
  27. 27.
    Binek J, Hany A, Heer M. Valproic-acid-induced pancreatitis Case report and review of the literature. J Clin Gastroenterol 1991; 13(6): 690–3PubMedCrossRefGoogle Scholar
  28. 28.
    Kayemba Kay’s Kabangu S, Bovier Lapierre M, Jalaquier E. Pancreatite aigue et acide valproique. Pediatrie 1991; 46(12): 839–43PubMedGoogle Scholar
  29. 29.
    Williams L, Emery J. Pancreatitis during sodium valproate treatment. Arch Dis Child 1983; 58: 543–4PubMedCrossRefGoogle Scholar
  30. 30.
    Rosenberg H, Ortega W. Hemorrhagic pancreatitis in a young child following valproic acid therapy. Clin Pediatr 1987; 26: 98–101CrossRefGoogle Scholar
  31. 31.
    Wyllie E, Wyllie R, Cruse R, et al. Pancreatitis associated with valproic acid therapy. Am J Dis Child 1984; 138: 912–4PubMedGoogle Scholar
  32. 32.
    Ng J, Disney A, Jones T, et al. Acute pancreatitis and sodium valproate. Med J Aust 1982; 21: 362Google Scholar
  33. 33.
    Murphy M, Lyon L, Taylor J. Valproic acid associated pancreatitis in an adult. Lancet 1981; I: 41–2CrossRefGoogle Scholar
  34. 34.
    Lott J, Bond L, Bobo R, et al. Valproic acid-associated pancreatitis: Report of three cases and a brief review. Clin Chem 1990; 36: 395–7PubMedGoogle Scholar
  35. 35.
    Coulter D, Allen R. Pancreatitis associated with valproic acid therapy for epilepsy. Ann Neurol 1980; 7: 92PubMedCrossRefGoogle Scholar
  36. 36.
    Camfield P, Bagnell P, Camfield C, et al. Pancreatitis due to valproic acid [letter]. Lancet 1979; I: 1198CrossRefGoogle Scholar
  37. 37.
    Batalden P, Van Dyne B, Cloyd J. Pancreatitis associated with valproic acid therapy. Pediatrics 1979; 64: 520–2PubMedGoogle Scholar
  38. 38.
    Parker P, Helinek G, Ghishan F, et al. Recurrent pancreatitis induced by valproic acid. Gastroenterology 1981; 80: 826–8PubMedGoogle Scholar
  39. 39.
    Sasaki M, Tonoda S, Aoki Y, et al. Pancreatitis due to valproic acid [letter]. Lancet 1980; I: 1196CrossRefGoogle Scholar
  40. 40.
    Committee on Safety of Medicines. Drug-induced pancreatitis. In: Rawlings M. Langman M, Wood S, et al, editors. Current Problems in Pharmacovigilance. London: Medicines Control Agency, 1994: 2–3Google Scholar
  41. 41.
    Walker R, Smith G, Barsoum N, et al. Preclinical toxicology of the anticonvulsant calcium valproate. Toxicology 1990; 63: 137–55PubMedCrossRefGoogle Scholar
  42. 42.
    Block M, Genant H, Kirsner J. Pancreatitis as an adverse reaction to salicylazosulfapyridine. N Engl J Med 1970; 282: 380–2PubMedCrossRefGoogle Scholar
  43. 43.
    Faintuch J, Mott C, Machado M. Pancreatitis and pancreatic necrosis during sulfasalazine therapy. Int Surg 1985; 70: 271–2PubMedGoogle Scholar
  44. 44.
    Suryapranta H, deVries H. Pancreatitis associated with sulfasalazine. BMJ 1986; 292: 732CrossRefGoogle Scholar
  45. 45.
    Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol 1994; 89: 789–91PubMedGoogle Scholar
  46. 46.
    Abdullah A, Scott R, Martin S. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with Ulcerative Colitis. J Pediatr Gastroenterol Nutr 1993; 17: 441–4PubMedCrossRefGoogle Scholar
  47. 47.
    Debongnie J, Dekoninck X. Sulfasalazine, 5-ASA and acute pancreatitis in Crohn’s Disease. J Clin Gastroenterol 1994; 19: 348–9PubMedCrossRefGoogle Scholar
  48. 48.
    Delgado Fontaneda E, Garcia Campos F, Ruiz Rebollo L, et al. Pancreatitis aguda por salazopirina — una asociacion excepcional. Rev Esp Enferm Dig 1991; 79: 439–40PubMedGoogle Scholar
  49. 49.
    Erdkamp F, Houben M, Ackerman E, et al. Pancreatitis induced by mesalazine. Neth J Med 1992; 41: 71–2PubMedGoogle Scholar
  50. 50.
    Garau P, Orenstein S, Neigut D, et al. Pancreatitis associated with olsalazine and sulfasalazine in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1994; 18: 481–5PubMedCrossRefGoogle Scholar
  51. 51.
    Radke M, Bartolomaeus G, Müller M, et al. Acute pancreatitis in Crohn’s disease due to 5-ASA therapy. J Pediatr Gastroenterol Nutr 1993; 16: 337–9PubMedCrossRefGoogle Scholar
  52. 52.
    Chiba M, Horie Y, Ishida H, et al. A case of salicylazosulfapyridine induced acute pancreatitis with positive lymphocyte stimulation test. Gastroenterol Jpn 1987; 22: 228–33PubMedGoogle Scholar
  53. 53.
    Brazer S, Medoff J. Sulfonamide-induced pancreatitis Pancreas 1988; 5: 583–6CrossRefGoogle Scholar
  54. 54.
    Van Arsdel PJ. Adverse drug reactions. St Louis: The C.V. Mosby Co, 1983: 1389–414Google Scholar
  55. 55.
    Poldermans D, Van Blankenstein M. Pancreatitis induced by disodium azodisalicylate. Am J Gastroenterol 1988; 83: 578–80PubMedGoogle Scholar
  56. 56.
    Howard J. Pancreatitis: multiple diseases with multiple causes and varying natural histories. In: Howard J, Jordan G, Reber H, editors. Surgical diseases of the pancreas. Philadelphia: Lea&Febiger, 1987: 204–7Google Scholar
  57. 57.
    Eisner T, Goldman I, Mc Kinley M. Crohn’s disease and pancreatitis. Am J Gastroenterol 1993; 88: 583–6PubMedGoogle Scholar
  58. 58.
    Weber P, Seibold F, Jenss H. Acute pancreatitis in Crohn’s disease. J Clin Gastroenterol 1993; 17(4): 286–91PubMedCrossRefGoogle Scholar
  59. 59.
    Bank S, Marks I. Hyperlipemic pancreatitis and the pill. Postgrad Med J 1970; 46: 576–88PubMedCrossRefGoogle Scholar
  60. 60.
    Glueck C, Scheel D, Fishback J, et al. Estrogen induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism 1972; 21: 657–66PubMedCrossRefGoogle Scholar
  61. 61.
    Mungall I, Hague R. Pancreatitis and the pill. Postgrad Med J 1975; 51: 855–7PubMedCrossRefGoogle Scholar
  62. 62.
    Davidoff F, Tishler S, Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med 1973; 289: 552–5PubMedCrossRefGoogle Scholar
  63. 63.
    Foster M, Powell D. Pancreatitis, multiple infarcts and oral contraception. Postgrad Med J 1975; 51: 667–9PubMedCrossRefGoogle Scholar
  64. 64.
    Parker W. Estrogen-induced pancreatitis (clinical conference). Clin Pharm 1983; 2: 75–9PubMedGoogle Scholar
  65. 65.
    Schaefer J, Steinmetz A, Dugi K, et al. Durch orale Kontrazeptiva induzierte Pankreatitis bei Hyperchylomikronamie-Syndrom. Deutsch Med Wochenschr 1995; 120: 325–8CrossRefGoogle Scholar
  66. 66.
    Glueck C, Lang J, Hamer T, et al. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994; 123: 59–64PubMedGoogle Scholar
  67. 67.
    Zorilla E, Hulse M, Hernandez A, et al. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives. J Clin Endocrinol 1968; 28: 1793–6CrossRefGoogle Scholar
  68. 68.
    Frick T, Fryd D, Sutherland D, et al. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients: data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg 1987; 154: 487–9PubMedCrossRefGoogle Scholar
  69. 69.
    Mixter CJ, Keynes M, Cope O. Further experience with pancreatitis as a diagnostic clue to hyperparathyroidism. N Engl J Med 1962; 266: 265–72CrossRefGoogle Scholar
  70. 70.
    Payne J, Tanenberg R. Hyperparathyroid crisis and acute necrotizing pancreatitis presenting as diabetic ketoacidosis. Am J Surg 1980; 140: 698–703PubMedCrossRefGoogle Scholar
  71. 71.
    Gafter U, Mandel EM, Har Zahav L, et al. Acute pancreatitis secondary to hypercalcemia: occurrence in a patient with breast carcinoma. JAMA 1976; 235: 2004–5PubMedCrossRefGoogle Scholar
  72. 72.
    May P, Levy R. Thyrotoxicosis associated with renal tubular necrosis and acute pancreatitis: a case report. Ann Intern Med 1976; 84: 569–70PubMedGoogle Scholar
  73. 73.
    Davies M, Kliniuk P, Adams P, et al. Familial hypocalciuric hypercalcemia and acute pancreatitis. BMJ 1981; 282: 1023–5PubMedCrossRefGoogle Scholar
  74. 74.
    Meltzer L, Palmon F, Paik Y, et al. Acute pancreatitis secondary to hypercalcemia of multiple myeloma. Ann Intern Med 1962; 57: 1008–12PubMedGoogle Scholar
  75. 75.
    Fernández-del Castillo C, Harringer W, Warshaw A, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325: 382–7PubMedCrossRefGoogle Scholar
  76. 76.
    Hochgelerent E, David D. Acute pancreatitis secondary to calcium infusion in a dialysis patient. Arch Surg 1974; 108: 218–9PubMedCrossRefGoogle Scholar
  77. 77.
    Izsak E, Shilke M, Roulet M, et al. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition. Gastroenterology 1980; 79: 555–8PubMedGoogle Scholar
  78. 78.
    Manson R. Acute pancreatitis secondary to iatrogenic hypercalcemia: implications of hyperalimentation. Arch Surg 1974; 108: 213–5PubMedCrossRefGoogle Scholar
  79. 79.
    Evans D, Slapak M. Pancreatitis in the hard water syndrome. BMJ 1975; 3: 748PubMedCrossRefGoogle Scholar
  80. 80.
    DeWaele B, Smith J, Willems G. Recurrent pancreatitis secondary to hypercalcemia following vitamin D poisoning. Pancreas 1989; 4: 378–80CrossRefGoogle Scholar
  81. 81.
    Leeson P, Fourman P. Acute pancreatitis from vitamin-D poisoning in a patient with parathyroid deficiency Lancet 1966; I: 1185–6CrossRefGoogle Scholar
  82. 82.
    Cates M, Singh S, Peick A, et al. Acute hypercalcemia, pancreatic duct permeability, and pancreatitis in cats. Surgery 1988; 104: 137–41PubMedGoogle Scholar
  83. 83.
    Frick T, Hailemariam S, Heitz P, et al. Acute hypercalcemia induces acinar cell necrosis and intraductal precipitates in the pancreas of cat and guinea pig. Gastroenterology 1990; 98: 1675–81PubMedGoogle Scholar
  84. 84.
    Kelly T. Relationship of hyperparathyroidism and pancreatitis. Arch Surg 1968; 97: 267–74PubMedCrossRefGoogle Scholar
  85. 85.
    Schmidt H, Creutzfeld T. Calciphylactic pancreatitis and pancreatitis in hyperparathyroidism. Clin Orthop 1970; 69: 135–45PubMedGoogle Scholar
  86. 86.
    Renner I, Savage W, Pantoja J, et al. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985; 30: 1005–18PubMedCrossRefGoogle Scholar
  87. 87.
    Bleyl U. Die sogenannte nervale Pankreatitis und ihre pathophysiologischen Grundlagen. Z Gastroenterol 1963; 1: 335–50Google Scholar
  88. 88.
    Dressel T, Goodale Jr R, Arneson M, et al. Pancreatitis as a complication of anticholinesterase insecticide intoxication. Ann Surg 1979; 189: 199–204PubMedCrossRefGoogle Scholar
  89. 89.
    Dagli A, Shaikh W. Pancreatic involvement in malathion-anti-cholinesterase insecticide intoxication: a study of 75 cases. Br J Clin Pract 1983; 37: 270–2PubMedGoogle Scholar
  90. 90.
    Lankisch P, Müller C, Niederstadt H, et al. Painless acute pancreatitis subsequent to anticholinesterase insecticide (parathion) intoxication. Am J Gastroenterol 1990; 85: 872–5PubMedGoogle Scholar
  91. 91.
    Marsh W, Vukov G, Conradi E. Acute pancreatitis after cutaneous exposure to an organophosphate insecticide. Am J Gastroenterol 1988; 83: 1158–60PubMedGoogle Scholar
  92. 92.
    Moore P, James O. Acute pancreatitis induced by acute organophosphate poisoning? Postgrad Med J 1981; 57: 660–2PubMedCrossRefGoogle Scholar
  93. 93.
    Moritz F, Droy J, Dutheil G, et al. Acute pancreatitis after carbamate insecticide intoxication. Intensive Care Med 1994; 20: 49–50PubMedCrossRefGoogle Scholar
  94. 94.
    Weizman Z, Sofer S. Acute pancreatitis in children with anticholinesterase insecticide intoxication. Pediatrics 1992; 90: 204–6PubMedGoogle Scholar
  95. 95.
    Dressel T, Goodale Jr R, Zweber B, et al. The effect of atropine and duct decompression on the evolution of diazinon-induced acute canine pancreatitis. Ann Surg 1982; 195: 424–34PubMedCrossRefGoogle Scholar
  96. 96.
    Frick T, Dalo S, O’Leary J, et al. Effects of insecticide, diazinon, on pancreas of dog, cat and guinea pig. J Environ Pathol Toxicol Oncol 1987; 7: 1–11PubMedGoogle Scholar
  97. 97.
    Laguna F, Soriano V, González-Labor J. Misdiagnosis in patients receiving treatment with pentavalent antimonal patients. Clin Infect Dis 1994; 19: 978–9PubMedGoogle Scholar
  98. 98.
    McCarthy A, Keystone J, Kain K. Pancreatitis occurring during therapy with stibogluconate: two case reports. Clin Infect Dis 1993; 17: 952–3PubMedCrossRefGoogle Scholar
  99. 99.
    Halim M, Alfurayh O, Kalin M, et al. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin Infect Dis 1993; 16: 397–9PubMedCrossRefGoogle Scholar
  100. 100.
    de Lalla F, Pellizer G, Gradoni L, et al. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral Leishmaniasis. Clin Infect Dis 1993; 16: 730–1PubMedCrossRefGoogle Scholar
  101. 101.
    Donovan K, White A, Cooke D, et al. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant patient. J Infect 1990; 21: 107–10PubMedCrossRefGoogle Scholar
  102. 102.
    Eckhauser M, Dokler M, Imbembo A. Diuretic-associated pancreatitis: a collective review and illustrative cases. Am J Gastroenterol 1987; 82: 865–70PubMedGoogle Scholar
  103. 103.
    Prigogine T, Futeral B, Kraytman M. Acute hemorrhagic pancreatitis associated with chlorthalidone therapy. Acta Clin Belg 1978; 33: 272Google Scholar
  104. 104.
    McCormick P, Malone D, Fitzgerald M, et al. Pancreatitis in sarcoidosis. BMJ 1985; 290: 1472–3PubMedCrossRefGoogle Scholar
  105. 105.
    Pickleman J, Straus F, Paloyan E. Pancreatitis associated with thiazide administration. Arch Surg 1979; 114: 1013–6PubMedCrossRefGoogle Scholar
  106. 106.
    Wenger J, Gross P. Acute hemorrhagic pancreatitis related to hydrochlorothiazide therapy. Gastroenterology 1964; 46: 768Google Scholar
  107. 107.
    Johnston D, Cornish A. Acute pancreatitis in patients receiving chlorothiazide. JAMA 1959; 170: 2054–6CrossRefGoogle Scholar
  108. 108.
    Diamond M. Hyperglycemic hyperosmolar coma associated with hydrochlorothiazide and pancreatitis. NY State J Med 1972; 72: 1741–2Google Scholar
  109. 109.
    Ances I, McClain C. Acute pancreatitis following the use of thiazide in pregnancy. South Med J 1971; 64: 267–9PubMedCrossRefGoogle Scholar
  110. 110.
    Jones M, Caldwell J. Acute hemorrhagic pancreatitis associated with administration of chlorthialidone. N Engl J Med 1962; 267: 1029–30PubMedCrossRefGoogle Scholar
  111. 111.
    Minkowitz S, Soloway H, Hall J, et al. Fatal hemorrhagic pancreatitis following chlorothiazide administration in pregnancy. Obstet Gynecol 1964; 24: 337–42PubMedGoogle Scholar
  112. 112.
    Rion J. Recurrent pancreatitis after treatment with hydrochlorthiazide. J Am Board Fam Pract 1994; 7: 74–6PubMedGoogle Scholar
  113. 113.
    Fuchs J, Keith M, Galanos A. Probable metolazone-induced pancreatitis. DICP 1989; 23: 711PubMedGoogle Scholar
  114. 114.
    Andersson P, Ellis G, Austin S. Metolazone-associated hypercalcemia and acute pancreatitis. Am J Med Sci 1991; 302: 235–7CrossRefGoogle Scholar
  115. 115.
    Mussche M, DeBroe M, Belpaire F, et al. Oral diazoxide contraindicated in severe hypertension with renal failure. Clin Nephrol 1975; 4: 99–103PubMedGoogle Scholar
  116. 116.
    Cornish A, McClellan J, Johnston D. Effects of chlorothiazide on the pancreas. N Engl J Med 1961; 265: 673–5PubMedCrossRefGoogle Scholar
  117. 117.
    Edwards B, Baer P, Sutton R, et al. Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron. J Clin Invest 1973; 52: 2418–27PubMedCrossRefGoogle Scholar
  118. 118.
    Pauwels A, Eliaszewicz M, Larrey D, et al. Pentamidine-induced pancreatitis in a patient with AIDS. J Clin Gastroenterol 1990; 12: 457–9PubMedCrossRefGoogle Scholar
  119. 119.
    Herer B, Chient T, Labrune S, et al. Pentamidine associated with pentamidine by aerosol. BMJ 1989; 298: 605PubMedCrossRefGoogle Scholar
  120. 120.
    Kumar S, Schnadig V, MacGregor M. Fatal acute pancreatitis associated with pentamidine therapy. Am J Gastroenterol 1989; 84: 451–3PubMedGoogle Scholar
  121. 121.
    Salmeron S, Petitpretz P, Katlama C, et al. Pentamidine and pancreatitis. Ann Intern Med 1986; 105: 140–1PubMedGoogle Scholar
  122. 122.
    Hart C. Aerosolized pentamidine and pancreatitis. Ann Intern Med 1989; 111: 691PubMedGoogle Scholar
  123. 123.
    Schwartz M, Cappell M. Pentamidine-associated pancreatitis. Dig Dis Sci 1989; 34: 1617–20PubMedCrossRefGoogle Scholar
  124. 124.
    Zuger A, Wolf B, El-Sadr W, et al. Pentamidine-associated fatal acute pancreatitis. JAMA 1986; 256: 2383–5PubMedCrossRefGoogle Scholar
  125. 125.
    Foisy M, Slayter K, Hewitt R, et al. Pancreatitis during intravenous pentamidine therapy in an AIDS patient with prior exposure to didanosine. Ann Pharmacother 1994; 28: 1025–8PubMedGoogle Scholar
  126. 126.
    Klatt E. Pathology of Pentamidine-induced pancreatitis. Arch Pathol Lab Med 1992; 116: 162–4PubMedGoogle Scholar
  127. 127.
    Sauleda J, Gea J, Aguar M, et al. Probable pentamidine-induced pancreatitis. Ann Pharmacother 1994; 28: 52–3PubMedGoogle Scholar
  128. 128.
    Pais J, Cazorla C, Novo E, et al. Massive haemorrhage from rupture of a pancreatic pseudocyst after pentamidine associated pancreatitis. Eur J Med 1992; 1: 251–3PubMedGoogle Scholar
  129. 129.
    Singh G, El-Gadi S, Sparks R. Pancreatitis associated with aerosolised pentamidine. Genitourin Med 1995; 71: 130–1PubMedGoogle Scholar
  130. 130.
    Murphey S, Josephs A. Acute pancreatitis associated with pentamidine therapy. Arch Intern Med 1981; 141: 56–8PubMedCrossRefGoogle Scholar
  131. 131.
    Buchard P, Sai P, Reach G. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 1982; 31: 40–5CrossRefGoogle Scholar
  132. 132.
    Boillot D, Veld P, Sai P. Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro. Diabetologia 1985; 28: 359–64PubMedCrossRefGoogle Scholar
  133. 133.
    Waalkes T, Denham C, De Vita V. Pentamidine: clinical pharmacologic correlations in man and mice. Clin Pharmacol Ther 1970; 11: 505–12PubMedGoogle Scholar
  134. 134.
    Roush M, McNutt R, Gray T. The adverse effect dilemma: quest for accessible information. Ann Intern Med 1993; 114: 298–9Google Scholar
  135. 135.
    Tilkemeier P, Thompson P. Acute pancreatitis possibly related to enalapril. N Engl J Med 1988; 318: 1275–6PubMedCrossRefGoogle Scholar
  136. 136.
    Pedro-Botet J, Miralles R, Coll J, et al. Captopril versus enalapril: cough versus pancreatitis. DICP Ann Pharmacother 1990; 24: 438–9Google Scholar
  137. 137.
    Dabaghi S. ACE inhibitors and pancreatitis. Ann Intern Med 1991; 115: 330–1PubMedGoogle Scholar
  138. 138.
    Maliekal J, Drake C. Acute pancreatitis associated with the use of lisinopril. Ann Pharmacother 1993; 27: 1465–6PubMedGoogle Scholar
  139. 139.
    Standridge J. Fulminant pancreatitis associated with lisinopril therapy. South Med J 1994; 87: 179–81PubMedCrossRefGoogle Scholar
  140. 140.
    Australian Adverse Drug Reaction Advisory Committee. Pancreatitis and ACE inhibitors [abstract]. Australian Adverse Drug Reactions Bulletin Aug 1989Google Scholar
  141. 141.
    Pratt C, Simone J, Zee P, et al. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. J Pediatr 1970; 77: 474–83PubMedCrossRefGoogle Scholar
  142. 142.
    Tan C, Chang S, Wee K. Acute hemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukemia — a case report. Singapore Med J 1974; 15: 278–82PubMedGoogle Scholar
  143. 143.
    Shaw M, Barnes C, Madden F, et al. L-asparaginase and pancreatitis. Lancet 1970; II: 721CrossRefGoogle Scholar
  144. 144.
    McLean R, Martin S, Lam-Po-Tang P. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982; II: 1401–2CrossRefGoogle Scholar
  145. 145.
    Jain R, Ramanan S. Iatrogenic pancreatitis. A fatal complication in the induction therapy for acute lymphocytic leukemia. Arch Intern Med 1978; 138: 1726PubMedCrossRefGoogle Scholar
  146. 146.
    Greenstein R, Nogeire C, Ohnuma T, et al. Management of aspariginase induced hemorrhagic pancreatitis complicated by pseudocyst. Cancer 1979; 43: 718–22PubMedCrossRefGoogle Scholar
  147. 147.
    Halskell C, Canellos G, Leventhal B, et al. L-asparaginase — therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med 1969; 281: 1028–34CrossRefGoogle Scholar
  148. 148.
    Oettgen H, Stephenson P, Schwartz M, et al. Toxicity of E. coli L-asparaginase in man. Cancer 1970; 25: 253–78PubMedCrossRefGoogle Scholar
  149. 149.
    Zubrod C. The clinical toxicities of L-asparaginase. Pediatrics 1970; 45: 555–8PubMedGoogle Scholar
  150. 150.
    Whitecar J, Bodey G, Harris J, et al. Current concepts: L-asparaginase. N Engl J Med 1970; 282: 732–4PubMedCrossRefGoogle Scholar
  151. 151.
    Loeb E, Hill J, Hill N, et al. Treatment of acute leukemia with L-asparaginase: recent results. Cancer Res 1970; 33: 204–18Google Scholar
  152. 152.
    Land V, Sutow W, Fernbach D, et al. Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972; 30: 339–47PubMedCrossRefGoogle Scholar
  153. 153.
    Jaffe N, Traggis D, Das L, et al. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia. Pediatrics 1972; 49: 590–5PubMedGoogle Scholar
  154. 154.
    Weetman R, Baehner R. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 1974; 34: 780–5PubMedCrossRefGoogle Scholar
  155. 155.
    Samuels B, Culbert S, Okamura J, et al. Early detection of chemotherapy-related pancreatic enlargement in children using abdominal sonography: a preliminary report. Cancer 1976; 38: 1515–23PubMedCrossRefGoogle Scholar
  156. 156.
    Nguyen D, Wilson D, Engelman E, et al. Serial sonograms to detect pancreatitis in children receiving L-asparaginase. South Med J 1987; 80: 1133–6PubMedCrossRefGoogle Scholar
  157. 157.
    Schein P, Rakieten N, Gordon M, et al. The toxicity of Escher-ichia coli L-asparaginase. Cancer Res 1969; 29: 426–34PubMedGoogle Scholar
  158. 158.
    Socinski M, Garwick M. Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients. Ann Intern Med 1988; 108: 567–8PubMedGoogle Scholar
  159. 159.
    Puckett J, Butler W, McFarland J. Pancreatitis and cancer chemotherapy. Ann Intern Med 1982; 97: 453PubMedGoogle Scholar
  160. 160.
    Newman C, Ellis D. Pancreatitis during combination chemotherapy. Clin Oncol 1979; 5: 83–4PubMedGoogle Scholar
  161. 161.
    Nevalainen T. Cytotoxicity of vinblastine and vincristine to pancreatic acinar cells. Virchows Arch B Cell Pathol 1975; 18: 119–27PubMedGoogle Scholar
  162. 162.
    Lerche A, Vyberg M, Kirkegaard E. Acute cholangitis and pancreatitis associated with sulindac. Histopathology 1987; 11: 647–53PubMedCrossRefGoogle Scholar
  163. 163.
    Zygmunt D, Williams H, Bienz S. Acute pancreatitis associated with long-term sulindac therapy. West J Med 1986; 144: 461–2PubMedGoogle Scholar
  164. 164.
    Sugerman H. Sulindac-induced acute pancreatitis mimicking gallstone pancreatitis. Am Surg 1989; 55: 536–8PubMedGoogle Scholar
  165. 165.
    Goldstein J, Laskin D, Ginsberg G. Sulindac associated with pancreatitis. Ann Intern Med 1980; 93: 115Google Scholar
  166. 166.
    Lilly E. Pancreatitis after administration of sulindac. JAMA 1981; 246: 2680PubMedCrossRefGoogle Scholar
  167. 167.
    Memon A. Pancreatitis and sulindac. Ann Intern Med 1982; 96: 139Google Scholar
  168. 168.
    Siefkin A. Sulindac and pancreatitis. Ann Intern Med 1980; 93: 932–3PubMedGoogle Scholar
  169. 169.
    Klein S, Khan M. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy. J Rheumatol 1983; 10: 512–3PubMedGoogle Scholar
  170. 170.
    Svane S. Acute pancreatitis after treatment with sulindac [Norwegian]. Tidsskr Nor Laegeforen 1992; 112: 1453PubMedGoogle Scholar
  171. 171.
    Guerra M. Toxicity of indomethacin: report of a case of acute pancreatitis. JAMA 1967; 200: 552–3PubMedCrossRefGoogle Scholar
  172. 172.
    Cobb T, Piero J. Acute pancreatitis associated with Ketoprofen. South Med J 1992; 85: 430–1PubMedCrossRefGoogle Scholar
  173. 173.
    Khan I, Edward N. Pancreatitis associated with diclofenac. Postgrad Med J 1993; 69: 486–7PubMedCrossRefGoogle Scholar
  174. 174.
    Du Ville L, Debeuckelaere S, Reynaert H, et al. Pancreatitis associated with Naproxen. Gastroenterology 1993; 88: 464Google Scholar
  175. 175.
    Sussmann S. Severe salicylism and acute pancreatitis Calif Med 1963; 99: 29–32Google Scholar
  176. 176.
    Cabooter M, Elewaut A, Barbier F. Salicylate-induced pancreatitis. Gastroenterology 1981; 80: 214–5PubMedGoogle Scholar
  177. 177.
    Haye O. Piroxicam and pancreatitis. Ann Intern Med 1986; 104: 895PubMedGoogle Scholar
  178. 178.
    Van Waalraven A, Edels M, Fong S. Pancreatitis caused by mefenaminic acid. Can Med Assoc J 1982; 126: 894Google Scholar
  179. 179.
    Bosch J, Valdes M, Oristrell J, et al. Oxyphenbutazone-induced sialadenitis, intrahepatic cholestasis and pancreatitis. Acta Gastroenterol Belg 1985; 48: 529–30PubMedGoogle Scholar
  180. 180.
    Ruppert G, Barth W. Ibuprofen hypersensitivity in systemic lupus erythematosus. South Med J 1981; 74: 241–2PubMedCrossRefGoogle Scholar
  181. 181.
    Caldarola V, Hassett J, Hall A, et al. Hemorrhagic pancreatitis associated with acetaminophen overdose. Am J Gastroenterol 1986; 81: 579–81PubMedGoogle Scholar
  182. 182.
    Coward R. Paracetamol induced acute pancreatitis. BMJ 1977; 1: 1086PubMedCrossRefGoogle Scholar
  183. 183.
    Gilmore I, Tourvas E. Paracetamol-induced acute pancreatitis. BMJ 1977; 1: 753PubMedCrossRefGoogle Scholar
  184. 184.
    Mofenson H, Caraccio T, Nawaz H, et al. Acetaminophen induced pancreatitis. J Toxicol Clin Toxicol 1991; 29: 223–30PubMedCrossRefGoogle Scholar
  185. 185.
    Olazabal A, Nascimento L. Effect of indomethacin, aspirin and fat-free diet on experimental pancreatitis in the rat. J Lab Clin Med 1980; 96: 570–6PubMedGoogle Scholar
  186. 186.
    Lankisch P, Koop H, Winkle K, et al. Indomethacin treatment of acute experimental pancreatitis in the rat. Scand J Gastroenterol 1978; 13: 629–33PubMedCrossRefGoogle Scholar
  187. 187.
    Jubert P. Clozapine related pancreatitis. Ann Intern Med 1994; 121: 722–3PubMedGoogle Scholar
  188. 188.
    Martin A. Acute pancreatitis associated with clozapine use. Am J Psychiatry 1992; 149: 714PubMedGoogle Scholar
  189. 189.
    Frankenburg F, Kando J. Eosinophilia, clozapine and pancreatitis. Lancet 1992; 340: 251PubMedCrossRefGoogle Scholar
  190. 190.
    Aziz S, Bergdahl L, Baldwin J, et al. Pancreatitis after cardiac and cardiopulmonary transplantation. Surgery 1985; 97: 653–61PubMedGoogle Scholar
  191. 191.
    Penn I, Durst A, Machado M, et al. Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg 1975; 105: 167–72CrossRefGoogle Scholar
  192. 192.
    Renning J, Warden G, Stevens L, et al. Pancreatitis after renal transplantation. Am J Surg 1972; 123: 293–6PubMedCrossRefGoogle Scholar
  193. 193.
    Johnson W, Nabseth D. Pancreatitis in renal transplantation. Ann Surg 1970; 171: 309–14PubMedCrossRefGoogle Scholar
  194. 194.
    Corrodi P, Knoblauch M, Binswanger U, et al. Pancreatitis after renal transplantation. Gut 1975; 16: 285–9PubMedCrossRefGoogle Scholar
  195. 195.
    Yoshimura N, Nakai I, Ohmori Y, et al. Effect of cyclosporine on endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988; 12: 11–7PubMedGoogle Scholar
  196. 196.
    Frick T, Fryd D, Goodale R, et al. Lack of association between azathioprine and acute pancreatitis in renal transplantation patients. Lancet 1991; 337: 251–2PubMedCrossRefGoogle Scholar
  197. 197.
    Sturdevant R, Singleton J, Deren J, et al. Azathioprine-related pancreatitis in patients with Crohn’s disease. Gastroenterology 1979; 77: 883–6PubMedGoogle Scholar
  198. 198.
    Huizenga K, Shorter R, Phillips S. Pancreatitis: a specific complication of azathioprine treatment of Crohn’s disease [abstract]. Gastroenterology 1976; 70: 895Google Scholar
  199. 199.
    Nogueira J, Freedman M. Acute pancreatitis as a complication of imuran therapy in regional enteritis. Gastroenterology 1972; 62: 1040–1PubMedGoogle Scholar
  200. 200.
    Major G, Moore P. Profound circulatory collapse due to azathioprine. J Royal Soc Med 1985; 78: 1052–3Google Scholar
  201. 201.
    Kawanishi H, Rudolph E, Bull F. Azathioprine-induced acute pancreatitis. N Engl J Med 1973; 289: 357PubMedCrossRefGoogle Scholar
  202. 202.
    Isenberg J. Pancreatitis, amylase clearance, and azathioprine. J Pediatrics 1978; 93: 1043–4CrossRefGoogle Scholar
  203. 203.
    Guillaume P, Grandjean E, Male P. Azathioprine-associated acute pancreatitis in the course of chronic active hepatitis. Dig Dis Sci 1984; 29: 78–80PubMedCrossRefGoogle Scholar
  204. 204.
    Paloyan D, Levin B, Simonowitz D. Azathioprine-associated acute pancreatitis. Am J Dig Dis 1977; 22: 839–40PubMedCrossRefGoogle Scholar
  205. 205.
    Hamed I, Lindeman R, Czerwinski A. Acute pancreatitis following corticosteroid and azathioprine therapy. Am J Med Sci 1978; 276: 211–9PubMedCrossRefGoogle Scholar
  206. 206.
    Broe P, Cameron J. Azathioprine and acute pancreatitis: Studies with an isolated perfused canine pancreas. J Surg Res 1983; 34: 159–63PubMedCrossRefGoogle Scholar
  207. 207.
    Dreiling D, Nacchiero M. The effect of imuran on pancreatic secretion. Am J Gastroenterol 1978; 69: 491–3PubMedGoogle Scholar
  208. 208.
    Kerstein M, Grabman J. Azathioprine as a treatment modality in acute hemorrhagic pancreatitis. Surg Forum 1978; 29: 453PubMedGoogle Scholar
  209. 209.
    Stenvinkel P, Alvestrand A. Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency. Acta Med Scand 1988; 224: 89–91PubMedCrossRefGoogle Scholar
  210. 210.
    Buchanan N, Cane R. Frusemide-induced pancreatitis. BMJ 1977; 3: 1417CrossRefGoogle Scholar
  211. 211.
    Call T, Malarkey W, Thomas F. Acute pancreatitis secondary to furosemide with associated hyperlipidemia. Am J Dig Dis 1977; 22: 835–8PubMedCrossRefGoogle Scholar
  212. 212.
    Jones P, Oelbaum M. Frusemide-induced pancreatitis. BMJ 1975; i: 133–4CrossRefGoogle Scholar
  213. 213.
    Strunge P. Frusemide-induced pancreatitis [letter]? BMJ 1975; 3: 434PubMedCrossRefGoogle Scholar
  214. 214.
    Wilson A, Mehra S, Gomersall C, et al. Acute pancreatitis associated with frusemide therapy. Lancet 1967; I: 105CrossRefGoogle Scholar
  215. 215.
    Thomas F, Sinar D, Caldwell J, et al. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology 1977; 73: 221–5PubMedGoogle Scholar
  216. 216.
    Schultz J, Adamson J, Workman W, et al. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963; 269: 999–1004PubMedCrossRefGoogle Scholar
  217. 217.
    Kunelis C, Peters J, Edmondson H. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965; 38: 359–77PubMedCrossRefGoogle Scholar
  218. 218.
    Whalley P, Adams R, Combes B. Tetracycline toxicity in pregnancy. JAMA 1964; 189: 357–62PubMedCrossRefGoogle Scholar
  219. 219.
    Peters R, Edmondson H, Mikkelsen W, et al. Tetracycline-induced fatty liver in non-pregnant women. Am J Surg 1967; 113: 622–32PubMedCrossRefGoogle Scholar
  220. 220.
    Damjanov I, Arnold R, Faour M. Tetracycline toxicity in a non-pregnant woman. JAMA 1968; 204: 934PubMedCrossRefGoogle Scholar
  221. 221.
    Jordan S, Ament M. Pancreatitis in children and adolescents. J Pediatr 1977; 91: 211–6PubMedCrossRefGoogle Scholar
  222. 222.
    Nicolau D, Mengedoht D, Kline J. Tetracycline-induced pancreatitis. Am J Gastroenterol 1991; 86: 1669–71PubMedGoogle Scholar
  223. 223.
    Torosis J, Vender R. Tetracycline-induced pancreatitis. J Clin Gastroenterol 1987; 9: 580–1PubMedCrossRefGoogle Scholar
  224. 224.
    Elmore M, Rogge J. Tetracycline-induced pancreatitis Gastroenterology 1981; 81: 1134–6PubMedGoogle Scholar
  225. 225.
    Celifarco A, Warschauer C, Burakoff R. Metronidazole-induced pancreatitis. Am J Gastroenterol 1989; 84: 958–60PubMedGoogle Scholar
  226. 226.
    Plotnick B, Cohen I, Tsang T, et al. Metronidazole-induced pancreatitis. Ann Intern Med 1985; 103: 891–2PubMedGoogle Scholar
  227. 227.
    Sanford K, Mayle J, Dean H, et al. Metronidazole-associated pancreatitis. Ann Intern Med 1988; 109: 756–7PubMedGoogle Scholar
  228. 228.
    Corey W, Doebbeling B, DeJong K, et al. Metronidazole-induced acute pancreatitis. Rev Infect Dis 1991; 13: 1213–5PubMedCrossRefGoogle Scholar
  229. 229.
    Friedman G, Selby J. How often does metronidazole induce pancreatitis? Gastroenterology 1990; 98: 1702–3PubMedGoogle Scholar
  230. 230.
    Sanford K, Mayle J, Dean H, et al. Excessive drug challenge. Ann Intern Med 1989; 110: 410Google Scholar
  231. 231.
    Scharer L, Smith J. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 1969; 71: 1113–20PubMedGoogle Scholar
  232. 232.
    Goldman A, Braman S. Isoniazid: a review with emphasis on adverse effects. Chest 1972; 62: 71–7PubMedCrossRefGoogle Scholar
  233. 233.
    Davidson P, Le H. Drug treatment of tuberculosis. Drugs 1992; 43: 651–73PubMedCrossRefGoogle Scholar
  234. 234.
    Chan K, Chan H, Lui S, et al. Recurrent acute pancreatitis induced by isoniazid. Tuber Lung Dis 1994; 75: 383–5PubMedCrossRefGoogle Scholar
  235. 235.
    Rabassa A, Trey G, Shukla U, et al. Isoniazid-induced pancreatitis. Ann Intern Med 1994; 121: 433–4PubMedGoogle Scholar
  236. 236.
    Dickson I. Acute pancreatitis following administration of Iso nicotinic acid hydrazide. Br J Tuberculosis 1956; 50: 277CrossRefGoogle Scholar
  237. 237.
    Perry W, Jenkins M, Stamp T. Lysosomal enzymes and pancreatitis during rifampicin therapy. Lancet 1979; I: 492CrossRefGoogle Scholar
  238. 238.
    Riska N, Mattson K. Adverse reactions during rifampicin treatment. Scand J Respir Dis 1972; 53: 87–96PubMedGoogle Scholar
  239. 239.
    Mattson K. Side effects of rifampicin. Scand J Respir Dis 1973; 82 Suppl.: 1–52Google Scholar
  240. 240.
    Poole G, Stradling P, Worlledge S. Potentially serious side effects of high-dose twice-weekly rifampicin. BMJ 1971; 3: 343–7PubMedCrossRefGoogle Scholar
  241. 241.
    Brockner J, Boisen E. Fatal multisystem toxicity after co-trimoxazole. Lancet 1978; I: 831CrossRefGoogle Scholar
  242. 242.
    Bartels R, van der Spek J, Oosten H. Acute pancreatitis due to sulfamethoxazole-trirnethoprim. South Med J 1992; 85: 1006–7PubMedCrossRefGoogle Scholar
  243. 243.
    Barret P, Thier S. Meningitis and acute pancreatitis associated with sulfamethoxazole. N Engl J Med 1963; 268: 36–7CrossRefGoogle Scholar
  244. 244.
    Antonow D. Acute pancreatitis associated with trimethoprim-sulfamethoxazole. Ann Intern Med 1986; 104: 363–5PubMedGoogle Scholar
  245. 245.
    Christophe J. Pancreatitis induced by nitrofurantoin. Gut 1993; 35: 712–3CrossRefGoogle Scholar
  246. 246.
    Nelis G. Nitrofurantoin-induced pancreatitis: report of a case. Gastroenterology 1983; 84: 1032–4PubMedGoogle Scholar
  247. 247.
    Davis T, Keeffe EB. Acute pancreatitis and acute hepatitis A. Am J Gastroenterol 1992; 87: 1648–50PubMedGoogle Scholar
  248. 248.
    Meylan P, Calandra T, Casey P, et al. Clinical experience with timetin in severe hospital infections. J Antimicrob Chemother 1986; 17 Suppl. C: 127–39PubMedGoogle Scholar
  249. 249.
    Hanline M. Acute pancreatitis caused by ampicillin. South Med J 1987; 80: 1069PubMedCrossRefGoogle Scholar
  250. 250.
    Hawksworth C. Acute pancreatitis associated with infusion of erythromycin lactobionate. BMJ 1989; 298: 190PubMedCrossRefGoogle Scholar
  251. 251.
    Gumaste V. Erythromycin-induced pancreatitis. Am J Med 1989; 86: 725PubMedCrossRefGoogle Scholar
  252. 252.
    Berger T, Cook W, O’Marcaigh A, et al. Acute pancreatitis in a 12 year old girl after an erythromycin overdose. Pediatrics 1992; 90: 624–6PubMedGoogle Scholar
  253. 253.
    Steed D, Brown B, Reilly J, et al. General surgical complications in heart and heart-lung transplantation. Surgery 1985; 98: 739–44PubMedGoogle Scholar
  254. 254.
    Calvo D, Patt Y, Wallace S, et al. Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy. Cancer 1980; 45: 1278–83PubMedCrossRefGoogle Scholar
  255. 255.
    Bunin N, Meyer W, Christensen M, et al. Pancreatitis following cisplatin: a case report. Cancer Treat Rep 1985; 69: 236–7PubMedGoogle Scholar
  256. 256.
    Bank L, Wright J. 6-mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease. Dig Dis Sci 1984; 29: 357–9PubMedCrossRefGoogle Scholar
  257. 257.
    Haber C, Meltzer S, Present D, et al. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology 1986; 91: 982–6PubMedGoogle Scholar
  258. 258.
    Present D, Korelitz B, Wisch N, et al. Treatment of Crohn’s disease with 6-mercaptopurine. N Engl J Med 1980; 302: 981–7PubMedCrossRefGoogle Scholar
  259. 259.
    Heuser E, Liebermann E, Donnell G, et al. Subcutaneous fat necrosis with acute hemorrhagic pancreatitis. Calif Med 1967; 106: 58–63PubMedGoogle Scholar
  260. 260.
    Cappell M, Das K. Rapid development of pancreatitis following reuse of 6-mercaptopurine. J Clin Gastroenterol 1989; 11: 679–81PubMedCrossRefGoogle Scholar
  261. 261.
    Woolley P, III. Hepatic and pancreatic damage produced by cytotoxic drugs. Cancer Treat Rev 1983; 10: 117–37PubMedCrossRefGoogle Scholar
  262. 262.
    Altman A, Dinndorf P, Quinn J. Acute pancreatitis in association with cytosine arabinoside therapy. Cancer 1982; 49: 1384–6PubMedCrossRefGoogle Scholar
  263. 263.
    Siemers R, Friedenberg W, Norflee R. High-dose cytosine arabinoside-associated pancreatitis. Cancer 1985; 56: 1940–2PubMedCrossRefGoogle Scholar
  264. 264.
    Izraeli S, Adamson P, Blaney S, et al. Acute pancreatitis after ifosfamide therapy. Cancer 1994; 74: 1627–8PubMedCrossRefGoogle Scholar
  265. 265.
    Lee S, Nichols J, Park H. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326: 589–93PubMedCrossRefGoogle Scholar
  266. 266.
    Békássy A, Wiebe T, Hochbergs P. Erwinase-induced pancreatitis. Lancet 1992; 340: 1552–3PubMedCrossRefGoogle Scholar
  267. 267.
    Kaplan M, Dreiling D. Steroids revised. Part II. Was cortisone responsible for the pancreatitis? Am J Gastroenterol 1977; 67: 141–7PubMedGoogle Scholar
  268. 268.
    Steinberg W, Lewis J. Steroid-induced pancreatitis: does it really exist? Gastroenterology 1981; 81: 799–808PubMedGoogle Scholar
  269. 269.
    Frick T, Speiser D, Bimmler D, et al. Drug-induced pancreatitis: further criticism. Dig Dis 1993; 11: 113–32PubMedCrossRefGoogle Scholar
  270. 270.
    Wilde H. Pancreatitis and phenformin. Ann Intern Med 1972; 77: 324PubMedGoogle Scholar
  271. 271.
    Coodley E, Derasse J, Carver J. Phenformin and pancreatitis. Ann Intern Med 1973; 78: 307PubMedGoogle Scholar
  272. 272.
    Chase H, Morgan G. Phenformin-associated pancreatitis. Ann Intern Med 1977; 87: 314–5PubMedGoogle Scholar
  273. 273.
    Graeber G, Marmor B, Hendel RC, et al. Pancreatitis and severe metabolic abnormalities due to phenformin therapy. Arch Surg 1976; 111: 1014–6PubMedCrossRefGoogle Scholar
  274. 274.
    Levitan A. Phenformin and pancreatitis. Ann Intern Med 1973; 78: 306–7PubMedGoogle Scholar
  275. 275.
    Ryan L, Hankwitz P, Banasiak M. Phenformin and pancreatitis. Ann Intern Med 1977; 87: 796PubMedGoogle Scholar
  276. 276.
    Wu S, Wolf J. Phenformin and pancreatitis. Ann Intern Med 1978; 88: 128PubMedGoogle Scholar
  277. 277.
    Sastri SV, Diaz-Arias AA, Marshall JB. Can pancreatitis be associated with amiodarone hepatotoxicity? J Clin Gastroenterol 1990; 12: 70–7PubMedCrossRefGoogle Scholar
  278. 278.
    Sebastian Domingo J, Simon Marco M, Uribarrena Echebarria R. Hepatic and pancreatic injury associated with amineptine therapy. J Clin Gastroenterol 1994; 18: 168–9PubMedCrossRefGoogle Scholar
  279. 279.
    Branch A. Pancreatic necrosis in ethyl alcohol, methyl alcohol and arsenic poisoning. Can Med Assoc J 1944; 51: 428–30PubMedGoogle Scholar
  280. 280.
    Durrington PN, Cairns SA. Acute pancreatitis: a complication of beta-blockade. BMJ 1982; 284: 1016PubMedCrossRefGoogle Scholar
  281. 281.
    Soman M, Swenson C. A possible cause of carbamazepine-induced pancreatitis. Drug Intell Clin Pharm 1985; 19: 925–6PubMedGoogle Scholar
  282. 282.
    Tsao C, Wright F. Acute chemical pancreatitis associated with carbamazepine intoxication. Epilepsia 1993; 34: 174–6PubMedCrossRefGoogle Scholar
  283. 283.
    Speckmann K. Über Pankreasschädigungen durch Tetrachlorkohlenstoff. Arztl Wochenschr 1953; 8: 1051–2Google Scholar
  284. 284.
    Moon HD. The pathology of fatal carbon-tetrachloride poisoning with special reference to the histogenesis of the hepatic and renal lesions. Am J Pathol 1950; 26: 1041–57PubMedGoogle Scholar
  285. 285.
    Keane FBV, Fennell JS, Tomkin GH. Acute pancreatitis, acute gastric dilatation and duodenal ileus following refeeding in anorexia nervosa. Ir J Med Sci 1978; 147: 191–2PubMedCrossRefGoogle Scholar
  286. 286.
    Casdorph HR. The efficacy and safety of cholestyramine therapy in hyperlipidemic patients. Ann Intern Med 1971; 74: 818Google Scholar
  287. 287.
    Committee of Principal Investigators. A co-operative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978; 40: 1069–118CrossRefGoogle Scholar
  288. 288.
    Roberge R, Martin T, Hodgman M, et al. Acute chemical pancreatitis associated with a tricyclic antidepressant (clomipramine) overdose. Clin Toxicol 1994; 32: 425–9CrossRefGoogle Scholar
  289. 289.
    Freemann JS, Panebianco PS. Colchicine overdosage: report of a case. J Am Osteopath Assoc 1982; 82: 252–4Google Scholar
  290. 290.
    Naidus RM, Rodvien R, Mielke H. Colchicine toxicity. Arch Intern Med 1977; 137: 394–6PubMedCrossRefGoogle Scholar
  291. 291.
    Chevalier X, Awada H, Baetz A, et al. Danazol induced pancreatitis and hepatitis. Clin Rheumatol 1990; 9: 239–41PubMedCrossRefGoogle Scholar
  292. 292.
    McCormick PA, O’Donoghue D, Brennan N. Diphenoxylate and pancreatitis. Lancet 1985; I: 752CrossRefGoogle Scholar
  293. 293.
    Deviere J, Reuse C, Askenasi R. Ischemic pancreatitis and hepatitis secondary to ergotamine poisoning. J Clin Gastroenterol 1987; 9: 350–2PubMedCrossRefGoogle Scholar
  294. 294.
    Thys F, Schapira M, Ghilain J, et al. Acute pancreatitis and fenfluramine. Gastroenterol Clin Biol 1994; 18: 385–6PubMedGoogle Scholar
  295. 295.
    Tchantz P, Favre H. Pancréatite nécrosante par intoxication à l’acide formique et brûlure à l’acide fluorhydrique. Schweiz Rundsch Med Prax 1975; 64: 487–90Google Scholar
  296. 296.
    Eisemann AD, Becker NJ, Miner PB, et al. Pancreatitis and gold treatment of rheumatoid arthritis. Ann Intern Med 1989; 111: 860–1PubMedGoogle Scholar
  297. 297.
    Schrogi JJ, Holt P, Hartley RC, et al. ‘Histamine-induced’ pancreatitis. Gastroenterology 1965; 49: 672–5Google Scholar
  298. 298.
    Calmus Y, Biour M, Bodin F, et al. Hépatites et pancréatite à l’indalpine. Gastroenterol Clin Biol 1985; 9: 266–8PubMedGoogle Scholar
  299. 299.
    Noseworthy J, Colodny AH, Eraklis AJ. Pancreatitis and intravenous fat: an association in patients with inflammatory bowel disease. J Pediatr Surg 1983; 18: 269–72PubMedCrossRefGoogle Scholar
  300. 300.
    Buckspan R, Woltering E, Waterhouse G. Pancreatitis induced by intravenous infusion of a fat emulsion in an alcoholic patient. South Med J 1984; 77: 251–2PubMedCrossRefGoogle Scholar
  301. 301.
    Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn’s disease. Gastroenterology 1986; 90: 1039–41PubMedGoogle Scholar
  302. 302.
    Flynn WJ, Freeman PG, Wickboldt LG. Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. Ann Intern Med 1987; 107: 63PubMedGoogle Scholar
  303. 303.
    Pluhar W. Ein Fall möglicher Lovastatin-induzierter Pankreatitis bei gleichzeitigem Gilbert-Syndrom. Wien Klin Wochenschr 1989; 101: 551–4PubMedGoogle Scholar
  304. 304.
    Bourry J, Sainty JM, Roux JJ, et al. Pancréatites aiguès aucours d’intoxications au méprobamate. Nouv Presse Med 1976; 5: 1918PubMedGoogle Scholar
  305. 305.
    Meyers DH. Pancreatitis, panniculitis and methandienone. Aust NZJ Med 1982; 12: 302–5Google Scholar
  306. 306.
    Sanford EW, Mitas JA, Swerdlin AHR. Pancreatitis due to methyldopa: case report. Mil Med 1980; 145: 399–400Google Scholar
  307. 307.
    Rominger JM, Gutierrez JG, Curtis D, et al. Methyldopa-induced pancreatitis. Am J Dig Dis 1978; 23: 756–8PubMedCrossRefGoogle Scholar
  308. 308.
    Van der Heide H, Ten Haaft MA, Strieker BMC. Pancreatitis caused by methyldopa. BMJ 1981; 282: 1930–1PubMedCrossRefGoogle Scholar
  309. 309.
    Stecyk O, Loludice TA, Demeter S, et al. Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 1985; 14: 597–9PubMedCrossRefGoogle Scholar
  310. 310.
    Tan W, Chapnick E, Abter E, et al. Paromycin-associated pancreatitis in HIV-related cryptosporidosis. Ann Pharmacother 1995; 29: 22–4PubMedGoogle Scholar
  311. 311.
    Bennett IL, Nation TC, Olley JF. Pancreatitis in methyl alcoholic poisoning. J Lab Clin Med 1952; 40: 405–9PubMedGoogle Scholar
  312. 312.
    Bennett IL, Freeman HC, Mitchell GL, et al. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases. Medicine 1953; 32: 431–63PubMedCrossRefGoogle Scholar
  313. 313.
    Alberti Flor J. Pancreatitis associated with ondansetron. J Natl Cancer Inst 1995; 87: 689–90PubMedCrossRefGoogle Scholar
  314. 314.
    Braganza JM, Jolley JE, Lee WR. Occupational chemicals and pancreatitis: a link? Int J Pancreatol 1986; 1: 9–19PubMedGoogle Scholar
  315. 315.
    Gradon J, Shulman R, Chapnick E, et al. Octreotide induced pancreatitis in a patient with acquired immunodeficiency syndrome. South Med J 1991; 84: 1410–1PubMedCrossRefGoogle Scholar
  316. 316.
    Friedenrich A, Sosset C, Bernard J, et al. Acute pancreatitis after short-term octreotide. Lancet 1991; 338: 52CrossRefGoogle Scholar
  317. 317.
    Lambrianides AL, Rosin RD. Acute pancreatitis complicating excessive intake of phenolphthalein. Postgrad Med J 1984; 60: 491–2PubMedCrossRefGoogle Scholar
  318. 318.
    Middleton SJ, Jacyna M, McClaren D, et al. Thomas HC. Hemorrhagic pancreatitis — a cause of death in severe potassium permanganate poisoning. Postgrad Med J 1990; 66: 657–8PubMedCrossRefGoogle Scholar
  319. 319.
    Falco JM, Thomas FB. Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med 1975; 83: 832–3Google Scholar
  320. 320.
    Jeffries JJ, Masson J. Pancreatitis following overdose with amoxapine and procyclidine. Can J Psychiatry 1985; 30: 546–7PubMedGoogle Scholar
  321. 321.
    Larsen RR, Sawyer RB, Sawyer KC, et al. Hemorrhagic pancreatitis complicating anticoagulant therapy. NY State J Med 1962; XX: 2397–9Google Scholar
  322. 322.
    Satake K, Nakashima Y. Drug-induced pancreatitis Philadelphia: Lea & Febiger, 1987: 322–9Google Scholar
  323. 323.
    Nakashima Y, Howard J. Drug-induced acute pancreatitis. Surg Gynecol Obstet 1977; 145: 105–9PubMedGoogle Scholar
  324. 324.
    Mallory A, Kern F. Drug-induced pancreatitis: a critical review. Gastroenterology 1980; 78: 813–20PubMedGoogle Scholar
  325. 325.
    Mallory A, Kern F. Drug-induced pancreatitis. Baillieres Clin Gastroenterol 1988; 2: 293–307PubMedCrossRefGoogle Scholar
  326. 326.
    Steinberg W. Acute drug and toxin induced pancreatitis. Hosp Pract Off Ed 1985; 20: 95–102PubMedGoogle Scholar
  327. 327.
    Banerjee A, Patel K, Grainger S. Drug-induced acute pancreatitis: a critical review. Med Toxicol Adverse Drug Exper 1989; 4: 186–98Google Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Teun Wilmink
    • 1
  • Thomas W. Frick
    • 1
  1. 1.Department of General SurgeryAddenbrooke’s HospitalCambridgeEngland

Personalised recommendations